Physician profile
Binod Sinha
NPI 1134293723
$32,931.44
in general payments reported to CMS, 2019-2025
18 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $877 · 2020: $28.61 · 2021: $31K · 2022: $71.58 · 2023: $219 · 2024: $104 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497 · Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.60 |
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $31,146.11 | 2021 | |
| Boston Scientific Corporation | $770.88 | 2019-2025 | Watchman Flx, General - Kidney Stone Disease, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $265.38 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $241.14 | 2021-2023 | |
| Janssen Biotech, INC. | $145.36 | 2019-2023 | Erleada |
| Pfizer INC. | $83.11 | 2019-2024 | |
| Procept Biorobotics Corporation | $64.59 | 2025 | |
| Telix Pharmaceuticals | $44.92 | 2024 | Illuccix |
| Ambu INC. | $31.15 | 2022 | |
| Dendreon Pharmaceuticals LLC | $24.28 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $18.91 | 2024 | Prolaris |
| Abc Home Medical Supply, INC. | $17.87 | 2025 | |
| Olympus America INC. | $15.47 | 2022 | |
| Urogen Pharma, INC. | $15.17 | 2023 | Jelmyto |
| Ferring Pharmaceuticals INC. | $13.60 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.24 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.72 | 2022 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Binod Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.